Literature DB >> 10960020

The influence of genetic variation on the splenic T cell cytokine and specific serum antibody responses to Porphyromonas gingivalis in mice.

E Gemmell1, T A Winning, D A Grieco, P S Bird, G J Seymour.   

Abstract

BACKGROUND: T cell cytokine profiles in the spleens and anti-Porphyromonas gingivalis antibodies in the sera of P. gingivalis-immunized BALB/c (H-2d), CBA/CaH (H-2k), C57BL6 (H-2b), and DBA/2J (H-2d, C5 deficient) mice were examined.
METHODS: Mice were immunized either by intraperitoneal injections of P. gingivalis outer membrane antigens and Freund's incomplete adjuvant weekly for 3 weeks or sham-immunized with PBS and adjuvant, followed by subcutaneous challenge with live organisms 1 week after the final immunization. Spleens were excised and blood samples collected by heart puncture at 0 and 7 days after challenge. Splenic CD4 and CD8 cells were stained for intracytoplasmic interleukin (IL)-4, interferon (IF)-gamma, and IL-10 and levels of anti-P. gingivalis antibodies in the serum samples determined by ELISA.
RESULTS: Lesion sizes in immunized BALB/c mice remained stable for the 7-day experimental period. Immunized CBA/CaH and C57BL6 mice exhibited large lesions at day 1 reducing by day 7 particularly in the latter strain. Lesions in immunized DBA/2J mice were still larger than the other strains at day 7. With the exception of DBA/2J mice, sham-immunized mice demonstrated lesions which did not show signs of healing by day 7. T cell cytokine responses in sham-immunized mice at day 0 were low, increasing to a variable degree by day 7 after challenge in the 4 strains. Immunized BALB/c mice demonstrated intermediate T cell responses while generally exhibiting a stronger IFN-gamma response than IL-4 or IL-10. Immunized CBA/CaH and C57BL6 mice showed weak T cell cytokine responses while immunized DBA/2J displayed the strongest T cell responses particularly in regard to IL-4 positive cells. Sham-immunized mice had low levels of serum anti-P. gingivalis antibody levels at day 0 with levels increasing significantly by day 7 after challenge. Antibody levels in immunized mice seemed to correlate with lesion sizes. Immunized C57BL6 mice had the highest antibody levels followed by CBA/CaH, BALB/c with DBA/2J exhibiting low levels. The T cell and B cell antibody responses in each strain appeared to exhibit an inverse relationship.
CONCLUSIONS: This study has shown that genetic differences at the level of H-2 haplotype induce variations in the local and T and B cell responses to P. gingivalis antigens. The responses of DBA/2J mice which have the same haplotype as BALB/c mice suggest that factors other than H-2 haplotype such as the C5 deficiency may influence this immune response. The significance of the specific antibody and T cell responses and of their inverse relationship to susceptibility to periodontal disease remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10960020     DOI: 10.1902/jop.2000.71.7.1130

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  4 in total

1.  Effect of Fusobacterium nucleatum on the T and B cell responses to Porphyromonas gingivalis in a mouse model.

Authors:  E Gemmell; P S Bird; C L Carter; K E Drysdale; G J Seymour
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

2.  Characterization of heat shock protein-specific T cells in atherosclerosis.

Authors:  Pauline Ford; Erica Gemmell; Philip Walker; Malcolm West; Mary Cullinan; Gregory Seymour
Journal:  Clin Diagn Lab Immunol       Date:  2005-02

Review 3.  The use of rodent models to investigate host-bacteria interactions related to periodontal diseases.

Authors:  Dana T Graves; Daniel Fine; Yen-Tung A Teng; Thomas E Van Dyke; George Hajishengallis
Journal:  J Clin Periodontol       Date:  2008-02       Impact factor: 8.728

4.  In vivo trafficking and immunostimulatory potential of an intranasally-administered primary dendritic cell-based vaccine.

Authors:  Prachi Vilekar; Vibhudutta Awasthi; Pallavi Lagisetty; Catherine King; Nathan Shankar; Shanjana Awasthi
Journal:  BMC Immunol       Date:  2010-12-10       Impact factor: 3.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.